366 related articles for article (PubMed ID: 18096439)
41. Outcomes in patients who have failed endoscopic therapy for dysplastic Barrett's metaplasia or early esophageal cancer.
Hunt BM; Louie BE; Schembre DB; Bohorfoush AG; Farivar AS; Aye RW
Ann Thorac Surg; 2013 May; 95(5):1734-40. PubMed ID: 23561804
[TBL] [Abstract][Full Text] [Related]
42. Advanced esophageal cancer in patients who underwent radiofrequency ablation for barrett esophagus with high-grade dysplasia.
Kim MP; Brown KN; Schwartz MR; Blackmon SH
Innovations (Phila); 2013; 8(1):17-22. PubMed ID: 23571789
[TBL] [Abstract][Full Text] [Related]
43. Endoscopic resection for Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.
Watson TJ
Semin Thorac Cardiovasc Surg; 2008; 20(4):310-9. PubMed ID: 19251170
[TBL] [Abstract][Full Text] [Related]
44. High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study.
Kara MA; Peters FP; Rosmolen WD; Krishnadath KK; ten Kate FJ; Fockens P; Bergman JJ
Endoscopy; 2005 Oct; 37(10):929-36. PubMed ID: 16189764
[TBL] [Abstract][Full Text] [Related]
45. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus.
Zaninotto G; Parenti AR; Ruol A; Costantini M; Merigliano S; Ancona E
Br J Surg; 2000 Aug; 87(8):1102-5. PubMed ID: 10931058
[TBL] [Abstract][Full Text] [Related]
46. Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia.
Nguyen NT; Schauer P; Luketich JD
Surgery; 2000 Mar; 127(3):284-90. PubMed ID: 10715983
[TBL] [Abstract][Full Text] [Related]
47. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus.
Oh DS; Hagen JA; Chandrasoma PT; Dunst CM; Demeester SR; Alavi M; Bremner CG; Lipham J; Rizzetto C; Cote R; Demeester TR
J Am Coll Surg; 2006 Aug; 203(2):152-61. PubMed ID: 16864027
[TBL] [Abstract][Full Text] [Related]
48. Prospective evaluation of the macroscopic types and location of early Barrett's neoplasia in 380 lesions.
Pech O; Gossner L; Manner H; May A; Rabenstein T; Behrens A; Berres M; Huijsmans J; Vieth M; Stolte M; Ell C
Endoscopy; 2007 Jul; 39(7):588-93. PubMed ID: 17611912
[TBL] [Abstract][Full Text] [Related]
49. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.
Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463
[TBL] [Abstract][Full Text] [Related]
50. What's new in columnar lined esophagus (Barrett's metaplasia)?
Tadiparthi R; Bansal A; Sharma P
Curr Opin Gastroenterol; 2008 Jul; 24(4):516-20. PubMed ID: 18622169
[TBL] [Abstract][Full Text] [Related]
51. Advances in endoscopic diagnosis and treatment of Barrett's esophagus.
Gaddam S; Sharma P
J Dig Dis; 2010 Dec; 11(6):323-33. PubMed ID: 21091894
[TBL] [Abstract][Full Text] [Related]
52. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma.
Maish MS; DeMeester SR
Ann Thorac Surg; 2004 Nov; 78(5):1777-82. PubMed ID: 15511474
[TBL] [Abstract][Full Text] [Related]
53. Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett's esophagus: a prospective cohort study.
Martinek J; Benes M; Brandtl P; Hucl T; Vasicek M; Voska L; Lanska V; Nosek V; Spicak J
Endoscopy; 2008 Sep; 40(9):711-6. PubMed ID: 18698534
[TBL] [Abstract][Full Text] [Related]
54. Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how?
Konda VJ; Ferguson MK
World J Gastroenterol; 2010 Aug; 16(30):3786-92. PubMed ID: 20698041
[TBL] [Abstract][Full Text] [Related]
55. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
56. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry.
Ganz RA; Overholt BF; Sharma VK; Fleischer DE; Shaheen NJ; Lightdale CJ; Freeman SR; Pruitt RE; Urayama SM; Gress F; Pavey DA; Branch MS; Savides TJ; Chang KJ; Muthusamy VR; Bohorfoush AG; Pace SC; DeMeester SR; Eysselein VE; Panjehpour M; Triadafilopoulos G;
Gastrointest Endosc; 2008 Jul; 68(1):35-40. PubMed ID: 18355819
[TBL] [Abstract][Full Text] [Related]
57. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.
DeMeester SR
Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209
[No Abstract] [Full Text] [Related]
58. Low-grade dysplasia in Barrett's esophagus has a high risk of progression.
Lim CH; Treanor D; Dixon MF; Axon AT
Endoscopy; 2007 Jul; 39(7):581-7. PubMed ID: 17611911
[TBL] [Abstract][Full Text] [Related]
59. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia.
Peyre CG; DeMeester SR; Rizzetto C; Bansal N; Tang AL; Ayazi S; Leers JM; Lipham JC; Hagen JA; DeMeester TR
Ann Surg; 2007 Oct; 246(4):665-71; discussion 671-4. PubMed ID: 17893503
[TBL] [Abstract][Full Text] [Related]
60. Comparative risk of recurrence of dysplasia and carcinoma after endoluminal eradication therapy of high-grade dysplasia versus intramucosal carcinoma in Barrett's esophagus.
Small AJ; Sutherland SE; Hightower JS; Guarner-Argente C; Furth EE; Kochman ML; Forde KA; Bewtra M; Falk GW; Ginsberg GG
Gastrointest Endosc; 2015 May; 81(5):1158-66.e1-4. PubMed ID: 25650071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
